These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25758276)

  • 1. Effects of guideline-based hypertension management in rural areas of Guangdong Province.
    Li G; Cai AP; Mo YJ; Chen JY; Wei RB; Huang YQ; Tang ST; Zhou YL; Feng YQ
    Chin Med J (Engl); 2015 Mar; 128(6):799-803. PubMed ID: 25758276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.
    Wang Z; Chen Z; Zhang L; Wang X; Hao G; Zhang Z; Shao L; Tian Y; Dong Y; Zheng C; Wang J; Zhu M; Weintraub WS; Gao R;
    Circulation; 2018 May; 137(22):2344-2356. PubMed ID: 29449338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on effects of community-based management of hypertension patients aged ≥35 years and influencing factors in urban and rural areas of China, 2010].
    Zeng XY; Zhang M; Li YC; Huang ZJ; Wang LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):612-7. PubMed ID: 27188348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and cost-effectiveness of a guideline-oriented primary healthcare hypertension management program in Beijing, China: results from a 1-year controlled trial.
    Wang X; Li W; Li X; An N; Chen H; Jan S; Ming G; Hua Q; Yan X; Sun N; Zhao D; Wu Y
    Hypertens Res; 2013 Apr; 36(4):313-21. PubMed ID: 23154592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007.
    Xu B; Xu Z; Xu X; Cai Q; Xu Y
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):217-22. PubMed ID: 23481521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study.
    Chen L; Zong Y; Wei T; Sheng X; Shen W; Li J; Niu Z; Zhou H; Zhang Y; Yuan Y; Chen Q; Zhong H
    BMC Public Health; 2015 Apr; 15():383. PubMed ID: 25886600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure control in patients with hypertension: a community-based study.
    Wang L; Wei T
    Clin Exp Hypertens; 2006 Jan; 28(1):41-6. PubMed ID: 16443563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of hypertension management in China: a community-based intervention study.
    Zheng X; Xiao F; Li R; Yin D; Xin Q; Yang H; Yin T; Wang L; Chen B
    Prim Health Care Res Dev; 2019 Jul; 20():e111. PubMed ID: 32799973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
    de Haro Moraes C; Figueiredo VN; de Faria AP; Barbaro NR; Sabbatini AR; Quinaglia T; Ferreira-Melo SE; Martins LC; Demacq C; Júnior HM
    J Hum Hypertens; 2013 Apr; 27(4):225-30. PubMed ID: 22810172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and treatment of hypertension in urban and riverside areas in Porto Velho, the Brazilian Amazon.
    Almeida RC; Dias DJ; Deguchi KT; Spesia CH; Coelho OR
    Postgrad Med; 2015 Jan; 127(1):66-72. PubMed ID: 25526235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort.
    Alam DS; Chowdhury MA; Siddiquee AT; Ahmed S; Niessen LW
    BMJ Open; 2014 Dec; 4(12):e004983. PubMed ID: 25537780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The positive effect of an intervention program on the hypertension knowledge and lifestyles of rural residents over the age of 35 years in an area of China.
    Huang S; Hu X; Chen H; Xie D; Gan X; Wu Y; Nie S; Wu J
    Hypertens Res; 2011 Apr; 34(4):503-8. PubMed ID: 21248756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.